Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
147 hedge funds and large institutions have $229M invested in Spectrum Pharmaceuticals Inc in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 45 increasing their positions, 47 reducing their positions, and 24 closing their positions.
11% more call options, than puts
Call options by funds: $879K | Put options by funds: $791K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 47
6% less funds holding
Funds holding: 156 → 147 (-9)
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
41% less capital invested
Capital invested by funds: $389M → $229M (-$160M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$16.2M |
| 2 |
AC
Armistice Capital
New York
|
+$14.6M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.28M |
| 4 |
BlackRock
New York
|
+$920K |
| 5 |
Rafferty Asset Management
New York
|
+$896K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$10.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.17M |
| 3 |
Two Sigma Investments
New York
|
-$4.97M |
| 4 |
Two Sigma Advisers
New York
|
-$2.76M |
| 5 |
Morgan Stanley
New York
|
-$2.17M |
SPPI Hedge Fund Activity: Q3 2021 in Review
147 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2021, worth a combined $229M — down 41% from $389M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of SPPI and 18 opened new positions — a net loss of 6 holders — while 47 trimmed existing stakes and 45 added.
The largest buyer was State Street, adding an estimated $16.2M. The largest seller was Macquarie Group, cutting an estimated $10.9M.
- 147 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2021, down from 156 in Q2 2021.
- Funds reported $229M of Spectrum Pharmaceuticals Inc stock for Q3 2021, down 41% quarter-over-quarter.
- 18 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2021 and 24 closed out, a net change of -6 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q3 2021 was State Street, an estimated $16.2M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q3 2021 was Macquarie Group, an estimated $10.9M sold.
Based on aggregated 13F filings for Q3 2021.